← Leaderboards
Udayan Guha
Sloan-Kettering Inst Can Research
$270,262
Attributed
$270,262
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $165.2K · FY2009–10$200K$150K$100K$50K$0
'09
'10
Funding mix
By agency
NIH$270,262 · 1
By mechanism
K99$270,262 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Tao Dao$540,804
- Cristina R Antonescu$10,810,455
- John Thomas Poirier$4,490,380
- Nathan Shugarts Devanapally$81,040
Others in their field
Top investigators on “Adenocarcinoma Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$36,362,948
- Richard M Peek · Vanderbilt University Medical Center$23,148,291
- Charles A Coltman · Southwest Oncology Group$18,209,974
- Andrea Califano · Columbia University Health Sciences$18,092,356
- Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr$17,618,287
- Matthew L Meyerson · Brigham And Women'S Hospital$16,697,735
Research focus
Adenocarcinoma CellAmino AcidsApoptosisArginylglutamateAwardBiopsyCancer BiologyCancer CellCancer Cell LineCancer EtiologyCancer PatientCareerCareer DevelopmentCause Of DeathCell Culture TechniquesCell GrowthCell LineCell ProliferationCellsCell SurvivalC-Erbb-1 Proto-OncogenesCessation Of LifeDoxycyclineAccounting